HAMBURG (dpa-AFX Broker) - Hauck Aufhäuser Investment Banking upgraded Stratec from "hold" to "buy" after quarterly figures, but lowered the price target from 55 to 50 euros. The diagnostics specialist's key figures signaled a reassuring development in gross margin, while sales were still negatively impacted by the "Covid hangover" in the IVD business, analyst Alexander Galitsa wrote in a study available Monday. However, the IVD market should remain intact and Stratec should gradually return to structural growth. In addition, profitability appears to be recovering faster than expected due to the good progress made so far in management's price adjustment efforts./edh/ajx

Publication of the original study: 30.10.2023 / 08:09 / CEST

First disclosure of original study: 30.10.2023 / 08:09 / CEST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------